ALDX
Price
$4.27
Change
-$0.14 (-3.17%)
Updated
Nov 14 closing price
111 days until earnings call
VNDA
Price
$5.10
Change
-$0.36 (-6.59%)
Updated
Nov 14 closing price
82 days until earnings call
Ad is loading...

ALDX vs VNDA

Header iconALDX vs VNDA Comparison
Open Charts ALDX vs VNDABanner chart's image
Aldeyra Therapeutics
Price$4.27
Change-$0.14 (-3.17%)
Volume$686.82K
CapitalizationN/A
Vanda Pharmaceuticals
Price$5.10
Change-$0.36 (-6.59%)
Volume$835.46K
CapitalizationN/A
ALDX vs VNDA Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALDX vs. VNDA commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and VNDA is a Buy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ALDX: $4.27 vs. VNDA: $5.10)
Brand notoriety: ALDX and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 155% vs. VNDA: 126%
Market capitalization -- ALDX: $254.28M vs. VNDA: $297.37M
ALDX [@Biotechnology] is valued at $254.28M. VNDA’s [@Biotechnology] market capitalization is $297.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, VNDA is a better buy in the long-term than ALDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 5 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 5 bearish.
  • VNDA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VNDA is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -20.04% price change this week, while VNDA (@Biotechnology) price change was +1.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

ALDX is expected to report earnings on Mar 06, 2025.

VNDA is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($297M) has a higher market cap than ALDX($254M). ALDX (21.652) and VNDA (20.853) have similar YTD gains .
ALDXVNDAALDX / VNDA
Capitalization254M297M86%
EBITDAN/AN/A-
Gain YTD21.65220.853104%
P/E RatioN/A137.00-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ALDX vs VNDA: Fundamental Ratings
ALDX
VNDA
OUTLOOK RATING
1..100
6225
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9589
PRICE GROWTH RATING
1..100
5743
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (38) in the Biotechnology industry is somewhat better than the same rating for VNDA (84). This means that ALDX’s stock grew somewhat faster than VNDA’s over the last 12 months.

ALDX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VNDA (100). This means that ALDX’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (89) in the Biotechnology industry is in the same range as ALDX (95). This means that VNDA’s stock grew similarly to ALDX’s over the last 12 months.

VNDA's Price Growth Rating (43) in the Biotechnology industry is in the same range as ALDX (57). This means that VNDA’s stock grew similarly to ALDX’s over the last 12 months.

VNDA's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for ALDX (100). This means that VNDA’s stock grew significantly faster than ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXVNDA
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 10 days ago
0%
Bullish Trend 3 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-3.17%
GSGTF - ALDX
56%
Loosely correlated
N/A
QSI - ALDX
47%
Loosely correlated
-1.52%
BBIO - ALDX
44%
Loosely correlated
-2.74%
FOLD - ALDX
44%
Loosely correlated
-2.70%
CRNX - ALDX
44%
Loosely correlated
+1.26%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with NTLA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-6.59%
NTLA - VNDA
39%
Loosely correlated
-6.15%
IKNA - VNDA
37%
Loosely correlated
-1.72%
ATAI - VNDA
34%
Loosely correlated
+1.48%
ALDX - VNDA
34%
Loosely correlated
-3.17%
SNGX - VNDA
32%
Poorly correlated
+1.38%
More